| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007592751 |
| P356 | DOI | 10.1007/S11883-016-0599-9 |
| P698 | PubMed publication ID | 27324637 |
| P2093 | author name string | Carel W le Roux | |
| Neil G Docherty | |||
| Audrey Melvin | |||
| P2860 | cites work | Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2 | Q73025325 |
| Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat | Q73196663 | ||
| Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet | Q73223976 | ||
| Oxyntomodulin inhibits food intake in the rat | Q74532297 | ||
| Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat | Q79301454 | ||
| Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans | Q79735513 | ||
| Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients | Q81072861 | ||
| Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy | Q81781892 | ||
| Ghrelin is a growth-hormone-releasing acylated peptide from stomach | Q22010951 | ||
| Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults | Q22250906 | ||
| A role for glucagon-like peptide-1 in the central regulation of feeding | Q24314317 | ||
| Identification of membrane-type receptor for bile acids (M-BAR) | Q24316461 | ||
| Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids | Q24628720 | ||
| The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control | Q24629879 | ||
| Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite | Q24669708 | ||
| Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans | Q27865308 | ||
| Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum | Q28117412 | ||
| Inhibition of food intake in obese subjects by peptide YY3-36 | Q28204942 | ||
| Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation | Q28290455 | ||
| Isolation and primary structure of human peptide YY | Q28292865 | ||
| Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. | Q28659292 | ||
| Central nervous system control of food intake | Q29547439 | ||
| Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery | Q29614192 | ||
| Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes | Q30548796 | ||
| The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss | Q30596646 | ||
| Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery | Q33959262 | ||
| Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes | Q34032014 | ||
| Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding | Q34062928 | ||
| A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans | Q34085069 | ||
| Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion | Q34109168 | ||
| Gut hormone PYY(3-36) physiologically inhibits food intake | Q34143493 | ||
| Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance | Q34325594 | ||
| Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance | Q34456568 | ||
| GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-cont | Q34511743 | ||
| Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans | Q34511955 | ||
| Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. | Q34514373 | ||
| Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial | Q34566570 | ||
| Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study | Q34598940 | ||
| Complete sequences of glucagon-like peptide-1 from human and pig small intestine | Q34678376 | ||
| Roux-en-Y Gastric Bypass Surgery Increases Respiratory Quotient and Energy Expenditure during Food Intake. | Q35670800 | ||
| NPY and Y receptors: lessons from transgenic and knockout models | Q35874617 | ||
| Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake | Q35893496 | ||
| Expression of ghrelin receptor mRNA in the rat and the mouse brain | Q35915057 | ||
| Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes | Q36240979 | ||
| Brainstem nutrient sensing in the nucleus of the solitary tract inhibits feeding. | Q36510898 | ||
| FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes | Q36573090 | ||
| Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial | Q36784428 | ||
| Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity | Q36935411 | ||
| Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms | Q37125945 | ||
| Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans | Q37377728 | ||
| Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans | Q37471710 | ||
| GOAT: the master switch for the ghrelin system? | Q37737473 | ||
| GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism | Q37826478 | ||
| ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors | Q38343331 | ||
| Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis | Q38625348 | ||
| Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia | Q38686646 | ||
| Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner | Q40011175 | ||
| Enteroglucagon | Q41387845 | ||
| Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line | Q41539691 | ||
| The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin. | Q42255930 | ||
| Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals | Q42501786 | ||
| Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates | Q42653582 | ||
| A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery | Q43254450 | ||
| Glucagon-like peptide-1 7-36: a physiological incretin in man. | Q43623564 | ||
| Ghrelin enhances appetite and increases food intake in humans | Q43819888 | ||
| Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI). | Q43962935 | ||
| Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure | Q44072283 | ||
| The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats | Q44165158 | ||
| The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38). | Q44400093 | ||
| Alterations in gut hormones after laparoscopic sleeve gastrectomy: a prospective clinical and laboratory investigational study | Q44603502 | ||
| Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat. | Q44670990 | ||
| Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells | Q44758175 | ||
| Effect of macronutrient composition on postprandial peptide YY levels | Q44931834 | ||
| Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. | Q45092471 | ||
| Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin | Q45105936 | ||
| PYY3-36 and pancreatic polypeptide reduce food intake in an additive manner via distinct hypothalamic dependent pathways in mice | Q45716976 | ||
| Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans. | Q46011128 | ||
| The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway | Q46464837 | ||
| Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. | Q47239778 | ||
| Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass | Q47263805 | ||
| Long-term persistence of hormonal adaptations to weight loss | Q47347342 | ||
| Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters | Q47356520 | ||
| A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management | Q47377383 | ||
| Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure | Q47945051 | ||
| Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism | Q47963424 | ||
| The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. | Q47996706 | ||
| Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons | Q48242769 | ||
| Characterization of blood-brain barrier permeability to PYY3-36 in the mouse | Q48308433 | ||
| PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats | Q48540815 | ||
| GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans | Q48632540 | ||
| Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. | Q48714353 | ||
| A novel endoscopic delivery system for placement of a duodenal-jejunal implant for the treatment of obesity and type 2 diabetes | Q48861303 | ||
| Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus | Q48883013 | ||
| The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats | Q49036890 | ||
| Impact of Duodenal-Jejunal Exclusion on Satiety Hormones. | Q50560792 | ||
| The effect of bariatric surgery on intestinal absorption and transit time. | Q51329344 | ||
| Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions. | Q51619791 | ||
| Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. | Q51664983 | ||
| Alterations of global gastrointestinal motility after sleeve gastrectomy: a prospective study | Q57112006 | ||
| PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans | Q57978507 | ||
| Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I | Q58012594 | ||
| Distribution and Immunocytochemical Colocalization of Peptide YY and Enteroglucagon in Endocrine Cells of the Rabbit Colon* | Q68304730 | ||
| Glucagon-37 (oxyntomodulin) and glucagon-29 (pancreatic glucagon) in human bowel: analysis by HPLC and radioreceptorassay | Q70598950 | ||
| Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36 | Q72125991 | ||
| [Proteolytic processing by dipeptidyl aminopeptidase IV generates receptor selectivity for peptide YY (PYY)] | Q72216354 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 49 | |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | Current Atherosclerosis Reports | Q20821076 |
| P1476 | title | The Gut as an Endocrine Organ: Role in the Regulation of Food Intake and Body Weight | |
| P478 | volume | 18 |
| Q37740010 | Control of Food Intake by Gastrointestinal Peptides: Mechanisms of Action and Possible Modulation in the Treatment of Obesity |
| Q90378259 | ISX-9 manipulates endocrine progenitor fate revealing conserved intestinal lineages in mouse and human organoids |
| Q30238919 | Novel Browning Agents, Mechanisms, and Therapeutic Potentials of Brown Adipose Tissue. |
Search more.